ConductScience.org, home

Paper34989

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.

Frishman W. Am Heart J, 1979. Cited by 187 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Papers, record 34989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34989

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.
PubMed
Journal
Am Heart J
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
187
iCite
Relative citation ratio, by iCite
10.8
iCite
Revised in PubMed
2019-06-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Frishman WW

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
Administration, Oral
Arrhythmias, Cardiac
Biological Availability
Half-Life
Humans
Intestinal Absorption
Protein Binding
Receptors, Adrenergic, beta
Solubility
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.

PMIDTitleJournalYearIn PapersSource
33572109Neuropsychiatric Consequences of Lipophilic Beta-Blockers.Medicina (Kaunas)2021https://conductscience.org/library/papers/33572109PubMed
30277556Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30277556PubMed
29974290Neurogenic hypertension: pathophysiology, diagnosis and management.Clin Auton Res2018https://conductscience.org/library/papers/29974290PubMed
28742547Celiprolol: A Unique Selective Adrenoceptor Modulator.Cardiol Rev2017https://conductscience.org/library/papers/28742547PubMed
26370555Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.Curr Cardiol Rep2015https://conductscience.org/library/papers/26370555PubMed
24271469Bioavailability of propranolol after oral, sublingual, and intranasal administration.Pharm Res1986https://conductscience.org/library/papers/24271469PubMed
22458739A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study.J Clin Hypertens (Greenwich)2012https://conductscience.org/library/papers/22458739PubMed
12083978Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.Clin Pharmacokinet2002https://conductscience.org/library/papers/12083978PubMed
8261714Individual variation in first-pass metabolism.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261714PubMed
7907178Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.Postgrad Med J1993https://conductscience.org/library/papers/7907178PubMed
6861867Pharmacokinetics of sotalol during pregnancy.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861867PubMed
6540864Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.Pflugers Arch1984https://conductscience.org/library/papers/6540864PubMed
6151506Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6151506PubMed
6143666Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6143666PubMed
6137389Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6137389PubMed
6125206Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125206PubMed
6125171Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125171PubMed
6121594Role of central beta-adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats.Br J Pharmacol1982https://conductscience.org/library/papers/6121594PubMed
6119623Effects of various structurally related beta-adrenoceptor blocking agents on maximum upstroke velocity of action potential in guinea-pig papillary muscles.Naunyn Schmiedebergs Arch Pharmacol1981https://conductscience.org/library/papers/6119623PubMed
6118072Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.Albrecht Von Graefes Arch Klin Exp Ophthalmol1981https://conductscience.org/library/papers/6118072PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34989

GET https://conductscience.org/api/papers/v1/34989/cited_by?page=2